These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 38321486)
1. Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer. Kuo WT; Kuo IY; Hsieh HC; Wu ST; Su WC; Wang YC J Biomed Sci; 2024 Feb; 31(1):20. PubMed ID: 38321486 [TBL] [Abstract][Full Text] [Related]
2. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment. Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869 [No Abstract] [Full Text] [Related]
3. Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy. Yang PS; Yu MH; Hou YC; Chang CP; Lin SC; Kuo IY; Su PC; Cheng HC; Su WC; Shan YS; Wang YC Theranostics; 2022; 12(1):340-361. PubMed ID: 34987649 [No Abstract] [Full Text] [Related]
4. Rab37 in lung cancer mediates exocytosis of soluble ST2 and thus skews macrophages toward tumor-suppressing phenotype. Tzeng HT; Su CC; Chang CP; Lai WW; Su WC; Wang YC Int J Cancer; 2018 Oct; 143(7):1753-1763. PubMed ID: 29717487 [TBL] [Abstract][Full Text] [Related]
5. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905 [TBL] [Abstract][Full Text] [Related]
6. Rab37 mediates exocytosis of secreted frizzled-related protein 1 to inhibit Wnt signaling and thus suppress lung cancer stemness. Cho SH; Kuo IY; Lu PF; Tzeng HT; Lai WW; Su WC; Wang YC Cell Death Dis; 2018 Aug; 9(9):868. PubMed ID: 30158579 [TBL] [Abstract][Full Text] [Related]
7. PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer. Sawada M; Goto K; Morimoto-Okazawa A; Haruna M; Yamamoto K; Yamamoto Y; Nakagawa S; Hiramatsu K; Matsuzaki S; Kobayashi E; Kawashima A; Hirata M; Iwahori K; Kimura T; Ueda Y; Kimura T; Wada H Int Immunol; 2020 May; 32(6):397-405. PubMed ID: 32009163 [TBL] [Abstract][Full Text] [Related]
8. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303 [TBL] [Abstract][Full Text] [Related]
9. Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer. Kim CG; Kim G; Kim KH; Park S; Shin S; Yeo D; Shim HS; Yoon HI; Park SY; Ha SJ; Kim HR J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34907028 [TBL] [Abstract][Full Text] [Related]
10. VAMP8, a vesicle-SNARE required for RAB37-mediated exocytosis, possesses a tumor metastasis suppressor function. Wang YS; Tzeng HT; Tsai CH; Cheng HC; Lai WW; Liu HS; Wang YC Cancer Lett; 2018 Nov; 437():79-88. PubMed ID: 30165196 [TBL] [Abstract][Full Text] [Related]
11. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8 Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359 [TBL] [Abstract][Full Text] [Related]
12. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy. Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008 [TBL] [Abstract][Full Text] [Related]
13. Diffuse large B-cell lymphoma: the significance of CD8 Zhu Q; Yang Y; Chen K; Zhang Q; Huang Y; Jian S J Transl Med; 2024 Feb; 22(1):174. PubMed ID: 38369502 [TBL] [Abstract][Full Text] [Related]
14. IL-33/NF-κB/ST2L/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer. Yang YE; Hu MH; Zeng YC; Tseng YL; Chen YY; Su WC; Chang CP; Wang YC Cell Death Dis; 2024 May; 15(5):356. PubMed ID: 38778059 [TBL] [Abstract][Full Text] [Related]
15. Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade. Biton J; Ouakrim H; Dechartres A; Alifano M; Mansuet-Lupo A; Si H; Halpin R; Creasy T; Bantsimba-Malanda C; Arrondeau J; Goldwasser F; Boudou-Rouquette P; Fournel L; Roche N; Burgel PR; Goc J; Devi-Marulkar P; Germain C; Dieu-Nosjean MC; Cremer I; Herbst R; Damotte D Am J Respir Crit Care Med; 2018 Oct; 198(7):928-940. PubMed ID: 29518341 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma. Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445 [TBL] [Abstract][Full Text] [Related]
17. Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8 Li A; Chang Y; Song NJ; Wu X; Chung D; Riesenberg BP; Velegraki M; Giuliani GD; Das K; Okimoto T; Kwon H; Chakravarthy KB; Bolyard C; Wang Y; He K; Gatti-Mays M; Das J; Yang Y; Gewirth DT; Ma Q; Carbone D; Li Z J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096533 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of the immune microenvironment and their clinical significance in non-small cell lung cancer patients with ALK-rearranged mutation. Zhang B; Zeng J; Zhang H; Zhu S; Wang H; He J; Yang L; Zhou N; Zu L; Xu X; Song Z; Xu S Front Immunol; 2022; 13():974581. PubMed ID: 36159860 [TBL] [Abstract][Full Text] [Related]
19. Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis. Tzeng HT; Tsai CH; Yen YT; Cheng HC; Chen YC; Pu SW; Wang YS; Shan YS; Tseng YL; Su WC; Lai WW; Wu LW; Wang YC Clin Cancer Res; 2017 May; 23(9):2335-2345. PubMed ID: 28151721 [No Abstract] [Full Text] [Related]
20. Evodiamine suppresses non-small cell lung cancer by elevating CD8 Jiang ZB; Huang JM; Xie YJ; Zhang YZ; Chang C; Lai HL; Wang W; Yao XJ; Fan XX; Wu QB; Xie C; Wang MF; Leung EL J Exp Clin Cancer Res; 2020 Nov; 39(1):249. PubMed ID: 33208183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]